Multicenter Study of Clinical Features of Breakthrough Acinetobacter Bacteremia during Carbapenem Therapy

Breakthrough Acinetobacter bacteremia during carbapenem therapy is not uncommon, and it creates therapeutic dilemmas for clinicians. This study was conducted to evaluate the clinical and microbiological characteristics of breakthrough Acinetobacter bacteremia during carbapenem therapy and to assess...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Lee, Yi-Tzu, Wang, Yung-Chih, Kuo, Shu-Chen, Chen, Chung-Ting, Liu, Chang-Pan, Liu, Yuag-Meng, Chen, Te-Li, Yang, Ya-Sung
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2017
Matèries:
Clinical Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5571354/
https://ncbi.nlm.nih.gov/pubmed/28674056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00931-17
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars